KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) EBT: 2009-2025

Historic EBT for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $87.2 million.

  • Charles River Laboratories International's EBT fell 4.43% to $87.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.2 million, marking a year-over-year decrease of 104.28%. This contributed to the annual value of $93.1 million for FY2024, which is 83.98% down from last year.
  • As of Q3 2025, Charles River Laboratories International's EBT stood at $87.2 million, which was up 22.10% from $71.4 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's EBT ranged from a high of $244.9 million in Q4 2022 and a low of -$216.8 million during Q4 2024.
  • Over the past 3 years, Charles River Laboratories International's median EBT value was $99.0 million (recorded in 2024), while the average stood at $79.0 million.
  • As far as peak fluctuations go, Charles River Laboratories International's EBT spiked by 67.18% in 2022, and later tumbled by 203.87% in 2024.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's EBT stood at $163.6 million in 2021, then spiked by 49.67% to $244.9 million in 2022, then declined by 14.79% to $208.7 million in 2023, then crashed by 203.87% to -$216.8 million in 2024, then decreased by 4.43% to $87.2 million in 2025.
  • Its EBT stands at $87.2 million for Q3 2025, versus $71.4 million for Q2 2025 and $36.0 million for Q1 2025.